---
title: "Damora Therapeutics, Inc. (DMRA.US)"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/DMRA.US.md"
symbol: "DMRA.US"
name: "Damora Therapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-03-11T17:32:08.687Z"
locales:
  - [en](https://longbridge.com/en/quote/DMRA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DMRA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DMRA.US.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/DMRA.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DMRA.US.md)


# Damora Therapeutics, Inc. (DMRA.US)

## 公司概况

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

| 项目 | 详情 |
|------|--------|
| 行业 | Biotechnology |
| 交易所 | US Market |
| 官网 | [galecto.com](https://galecto.com) |

## 关键驱动因素
> *AI 分析的影响该股票表现的关键因素*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Longbridge 独家多因子评级模型*
> 更新时间: 1970-01-01T00:00:00.000Z

**综合:  (0.00)**

## 估值分析

| 指标 | 当前值 | 行业排名 | 最高 | 中位 | 最低 |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -96.99 | - | - | - | - |
| PB | 230.53 | - | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## 机构观点

### 分析师评级分布

> 截至 2026-03-11T04:00:00.000Z

分析师总数: **4**

| 评级 | 数量 | 占比 |
|--------|-------|-----------| 
| Buy | 4 | 100% |

### 目标价预测

| 指标 | 价格 |
|--------|-------|
| 当前价格 | 4.33 |
| 最高目标价 | undefined |
| 最低目标价 | undefined |

## 参考链接

- [公司概况 — 简介、高管、股东、业务构成](https://longbridge.com/zh-CN/quote/DMRA.US/overview.md)
- [财务报表 — 利润表、资产负债表、现金流、分红方案](https://longbridge.com/zh-CN/quote/DMRA.US/norm.md)
- [相关新闻](https://longbridge.com/zh-CN/quote/DMRA.US/news.md)
- [公告 — 公司公告与监管文件](https://longbridge.com/zh-CN/quote/DMRA.US/filings.md)

---

> **免责声明: 本文仅供参考，不构成任何投资建议。**